Multiple studies have shown that increased ITGA5 expression predicts poor prognosis of tumors, such as ovarian cancer (Gong et al., 2016), breast cancer (Xiao et al., 2018), and lung cancer (Zheng et al., 2016). Here, ITGA5 is linked to lung carcinoma.